Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Logroscino

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Neurology|July 20, 2007
Status epilepticus: an independent outcome predictor after cerebral anoxiaA O Rossetti, G Logroscino, L Liaudet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2005
Incidence of amyotrophic lateral sclerosis in southern Italy: a population based studyG Logroscino, E Beghi, S Zoccolella, et al.
Current Medicinal Chemistry|November 18, 2011
Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulationF Panza, V Frisardi, V Solfrizzi, et al.
International Journal of Immunopathology and Pharmacology|June 15, 2011
Bone integration of new stemless hip implants (proxima vs. nanos). A DXA study: preliminary resultsG Logroscino, V Ciriello, E D'Antonio, et al.
Acta Neurologica Scandinavica|March 13, 2018
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosisR Tortelli, S Arcuti, M Copetti, et al.
The Journal of Nutrition, Health & Aging|March 4, 2015
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic reviewF Panza, V Solfrizzi, M R Barulli, et al.
Neurology|May 5, 1998
Systemic iron metabolism and mortality from Parkinson's diseaseK Marder, G Logroscino, M X Tang, et al.
Current Alzheimer Research|May 25, 2011
Mediterranean diet in predementia and dementia syndromesV Solfrizzi, V Frisardi, D Seripa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2007
Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based studyS Zoccolella, E Beghi, G Palagano, et al.
European Journal of Neurology|November 5, 2024
Mild cognitive impairment and early Alzheimer's disease eligibility for disease modification therapies in a tertiary centre for cognitive disorders: A simultaneous real-word study on aducanumab and lecanemabG Logroscino, D Urso, V Gnoni, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Neurology|July 20, 2007
Status epilepticus: an independent outcome predictor after cerebral anoxiaA O Rossetti, G Logroscino, L Liaudet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2005
Incidence of amyotrophic lateral sclerosis in southern Italy: a population based studyG Logroscino, E Beghi, S Zoccolella, et al.
Current Medicinal Chemistry|November 18, 2011
Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulationF Panza, V Frisardi, V Solfrizzi, et al.
International Journal of Immunopathology and Pharmacology|June 15, 2011
Bone integration of new stemless hip implants (proxima vs. nanos). A DXA study: preliminary resultsG Logroscino, V Ciriello, E D'Antonio, et al.
Acta Neurologica Scandinavica|March 13, 2018
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosisR Tortelli, S Arcuti, M Copetti, et al.
The Journal of Nutrition, Health & Aging|March 4, 2015
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic reviewF Panza, V Solfrizzi, M R Barulli, et al.
Neurology|May 5, 1998
Systemic iron metabolism and mortality from Parkinson's diseaseK Marder, G Logroscino, M X Tang, et al.
Current Alzheimer Research|May 25, 2011
Mediterranean diet in predementia and dementia syndromesV Solfrizzi, V Frisardi, D Seripa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2007
Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based studyS Zoccolella, E Beghi, G Palagano, et al.
European Journal of Neurology|November 5, 2024
Mild cognitive impairment and early Alzheimer's disease eligibility for disease modification therapies in a tertiary centre for cognitive disorders: A simultaneous real-word study on aducanumab and lecanemabG Logroscino, D Urso, V Gnoni, et al.
Pageof 9